
Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 197
Selected: 0
NCT ID | Title | ||
---|---|---|---|
NCT04447326 | Toripalimab, Endostar Combined With Radiotherapy and Chemotherapy for Nasopharyngeal Carcinoma | ||
NCT04555226 | The Efficacy of Lymph Node Dissection for Stage IIICr of Cervical Cancer(CQGOG0103) | ||
NCT02605226 | Cryoablation Therapy or Radiotherapy Therapy for Stage III Prostate Cancer | ||
NCT06136026 | Integrated Chinese and Western Medicine Specialized Disease Cohort for Colorectal Cancer | ||
NCT01939574 | A Explore Study of Bevacizumab Combined With Conventional Therapy in Glioblastoma | ||
NCT01630174 | IMRT/Pemetrexed/Cisplatin in Esophageal Cancer | ||
NCT05351320 | WX-0593 Combined With Concurrent Chemoradiotherapy in Unresectable Locally Advanced NSCLC | ||
NCT04981665 | A Study to Evaluate TACE Sequential Tislelizumab as Adjuvant Therapy in Participants With HCC at High Risk of Recurrence After Curative Resection | ||
NCT03791125 | Phase I Single-dose Escalation Clinical Trial of Salvianolic Acid A Tablets | ||
NCT06078930 | Development of Novel Gastric Cancer Screening and Diagnosis Technologies Using Tongue Imaging and Study of Tongue Image Changes Mechanisms | ||
NCT06802757 | Posaconazole Plus Pembrolizumab and Chemotherapy vs Pembrolizumab and Chemotherapy in Neoadjuvant Therapy for Triple Negative Breast Cancer | ||
NCT06683066 | Study on Human Bioequivalence of Triprerelin Acetate for Injection | ||
NCT06714266 | Trilaciclib in Preventing Hematopoietic Suppression in Patients with Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma | ||
NCT05099848 | A Trial of Conversion Treatment of HAIC Combined With Camrelizumab and Apatinib for Unresected Hepatocellular Carcinoma | ||
NCT05933967 | A Study of Orelabrutinib Plus R-CHOP in Treatment-naïve Patients With Double Expression Diffuse Large B-cell Lymphoma | ||
NCT02793791 | Prophylactic Treatment of Hepatic Dysplastic Nodules in HBsAg Positive Patients | ||
NCT02272894 | A Trial to Evaluate the Superior Mesenteric Vein (14V) Lymphadenectomy for Distal Advanced Gastric Cancer | ||
NCT05955391 | TGRX-326 Chinese Phase II for Advanced Non-small Cell Lung Cancer (NSCLC) | ||
NCT04793672 | Establishment of Tongue Image Database and Machine Learning Model for Malignant Tumors Diagnosis | ||
NCT06288360 | Neoadjuvant Immunochemotherapy in PD-L1-negative LACC | ||
NCT02580279 | Study of Epigallocatechin-3-gallate (EGCG) for Skin Prevention in Patients With Breast Cancer Receiving Adjuvant Radiotherapy | ||
NCT02443064 | Pharmacokinetics/ Pharmacodynamics (PK/PD) Study of Vancomycin | ||
NCT06167421 | Comparison of Kimura Versus Warshaw Technique for Laparoscopic Spleen-Preserving Distal Pancreatectomy | ||
NCT01053390 | New Chemotherapy Regimen in the Treatment of Advanced Gallbladder Carcinoma | ||
NCT05900921 | Trilaciclib Prior to Chemotherapy Plus Tislelizumab as 1L Treatment for Advanced Squamous Non-Small-Cell Lung Cancer | ||
NCT03116984 | A Study of Comparison of TACE Combination With and Without EBRT for Advanced HCC | ||
NCT02284490 | High-dose Pemetrexed to Treat Lung Adenocarcinoma With Brain Metastases | ||
NCT05323890 | Tislelizumab Combined With Neoadjuvant Radiotherapy and Chemotherapy for Resectable Esophageal Squamous Cell Carcinoma. | ||
NCT06850090 | Neoadjuvant Radiotherapy for Rectal Adenocarcinoma With Capecitabine Versus TAS-102 | ||
NCT04246502 | Capecitabine Plus Pyrotinib Versus Capecitabine Plus Trastuzumab and Pertuzumab in the First-line Treatment of HER2-positive Metastatic Breast Cancer | ||
NCT05901779 | Effect of Probiotic Supplements on Gastric Cancer Patients Receiving Neoadjuvant Chemotherapy | ||
NCT06515964 | China Early Esophageal Cancer Cohort | ||
NCT03373708 | Risk and Clinical Benefit of Chemotherapy and Intensive Endocrine Therapy for Luminal B1 Early-stage Breast Cancer | ||
NCT06847555 | Phase I-II Clinical Study of Taurine for External Use in the Prevention and Treatment of Acute Radiation Skin Injury | ||
NCT07000643 | Phase III Non-Inferiority Trial of Proton Versus Photon Therapy for Nasopharyngeal Carcinoma | ||
NCT06356584 | Fruquintinib/Regorafenib Combined With Sintilimab ± Radiotherapy for Third-line Treatment of Metastatic Colorectal Cancer (FREST-CRC) | ||
NCT06686979 | PDO Based Drug Sensitive Test in R/M SGC | ||
NCT01714908 | Phase II Study of Erlotinib With Concurrent Radiotherapy in Unresectable NSCLC With Activating Mutation of EGFR in Exon 19 or 21 | ||
NCT02630108 | TACE Combined With Synchronous Radiofrequency /Microwave Ablation to Treat Large and Huge Hepatocellular Carcinoma | ||
NCT02721550 | A Trial of CMNa Combined With Preoperatie Concurrent Chemoradiotherapy for Locally Advanced ESCC | ||
NCT05934864 | Different Molecular Subtypes of Peripheral T-cell Lymphoma, a Real-world Registry Study. (TRUST) | ||
NCT04047823 | Temperature and Injury in Radiotherapy Radiation Skin Injury | ||
NCT04095390 | A Phase Ⅱ Trial of Pyrotinib Combination With CDK4/6 Inhibitor SHR6390 in Patients Prior Trastuzumab-treated Advanced HER2-Positive Breast Cancer | ||
NCT02544243 | Vinorelbine/Gemcitabine Versus Vinorelbine/Cisplatin in Metastatic Breast Cancer | ||
NCT02790190 | Individualized Adaptive Radiotherapy Based on PET/CT and IMRT for Locally Advanced Non-Small Cell Lung Cancer (NSCLC) | ||
NCT04880746 | Efficacy and Safety of Cladribine Combined With BEAC Pretreatment Regimen in the Treatment of Peripheral T-cell Lymphoma: a Multicenter Clinical Study | ||
NCT06340204 | Weekly Irinotecan Liposomes in Recurrent or Refractory Ewing Sarcoma | ||
NCT06841172 | Continuation of First-line Therapy With Radiotherapy Versus Early Switch to Second-line Therapy in Oligoprogressive HCC | ||
NCT03703427 | Capecitabine Versus Vinorelbine in High Risk Breast Cancer With Pathologic Residual Tumors After Preoperative Chemotherapy | ||
NCT06288373 | Neoadjuvant Chemoimmunotherapy Versus Concurrent Chemoradiotherapy for LACC |